Immunity · 1997 · 1.1K citations · 42 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsImmunogeneticsMolecular ImmunologyHla TypingMajor Histocompatibility ComplexMolecular TypingNatural Killer Cell BiologyPopulation ImmunogeneticsReceptor PolymorphismsHuman DiversityHuman Population StructureInhibitory Killer Cell Immunoglobulin-like ReceptorsKiller Cell Immunoglobulin-like Receptor Gene ExpressionKiller Cell Immunoglobulin-like Receptor Gene PolymorphismKiller Cell Immunoglobulin-like Receptor HaplotypesNatural Killer Cell Receptor Polymorphisms
Molecular typing of KIR and CD94:NKG2 genes was performed on 68 donors. KIR gene content varied among individuals, with 20 distinct phenotypes and two haplotype groups (A and B) of roughly equal frequency; most people expressed inhibitory KIR for HLA‑B/C ligands, while noninhibitory KIR genes were more variable, and allelic polymorphism was observed in five genes, indicating a polygenic and polymorphic KIR locus.
The presence and expression of killer inhibitory receptor (KIR) and CD94:NKG2 genes from 68 donors were analyzed using molecular typing techniques. The genes encoding CD94:NKG2 receptors were present in each person, but KIR gene possession varied. Most individuals expressed inhibitory KIR for the three well-defined HLA-B and -C ligands, but noninhibitory KIR genes were more variable. Twenty different KIR phenotypes were defined. Two groups of KIR haplotypes were distinguished and occurred at relatively even frequency. Group A KIR haplotypes consist of six genes: the main inhibitory KIR, one noninhibitory KIR, and a structurally divergent KIR. Allelic polymorphism within five KIR genes was detected. Group B comprises more noninhibitory KIR genes and contains at least one additional gene not represented in group A. The KIR locus therefore appears to be polygenic and polymorphic within the human population.
42
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Klas Kärre, Hans Ljunggren, Gerald E. Piontek et al. · Nature · 1986 · 2.1K citations
Life Sciences, Immunology, Oncology +12
Recruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor
Deborah N. Burshtyn, Andrew M. Scharenberg, Nicolai Wagtmann et al. · Immunity · 1996 · 615 citations · Full text